Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Experimental & Clinical Cancer Research : CR
|
February 7, 2026
GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma
Aleksandra Adamska, Hanna Chahin, Erick Andrés Muciño-Olmos, et al.
Scientific Reports
|
January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
Liselot M Mus, Irina Lambertz, Shana Claeys, et al.
Life Science Alliance
|
September 22, 2020
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
Meliha Mehmeti-Ajradini, Caroline Bergenfelz, Anna-Maria Larsson, et al.
Cancer Research
|
August 30, 2018
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
Noémie Braekeveldt, Kristoffer von Stedingk, Susanne Fransson, et al.
Nature Communications
|
January 28, 2015
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
Linda Holmquist Mengelbier, Jenny Karlsson, David Lindgren, et al.
Science Translational Medicine
|
October 12, 2022
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
Ani Grigoryan, Dimitra Zacharaki, Alexander Balhuizen, et al.
EMBO Molecular Medicine
|
December 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma
Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Experimental & Clinical Cancer Research : CR
|
February 7, 2026
GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma
Aleksandra Adamska, Hanna Chahin, Erick Andrés Muciño-Olmos, et al.
Scientific Reports
|
January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
Liselot M Mus, Irina Lambertz, Shana Claeys, et al.
Life Science Alliance
|
September 22, 2020
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
Meliha Mehmeti-Ajradini, Caroline Bergenfelz, Anna-Maria Larsson, et al.
Cancer Research
|
August 30, 2018
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
Noémie Braekeveldt, Kristoffer von Stedingk, Susanne Fransson, et al.
Nature Communications
|
January 28, 2015
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
Linda Holmquist Mengelbier, Jenny Karlsson, David Lindgren, et al.
Science Translational Medicine
|
October 12, 2022
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
Ani Grigoryan, Dimitra Zacharaki, Alexander Balhuizen, et al.
EMBO Molecular Medicine
|
December 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma
Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Page
of 5